Radiation pneumonitis and early circulatory cytokine markers

Engelstad, 1940, Pulmonary lesions after roentgen and radium irradiation, Am J Roentgenol, 43, 676

Roberts, 1993, Radiation pneumonitis: A possible lymphocyte-mediated hypersensitivity reaction, Ann Intern Med, 118, 696, 10.7326/0003-4819-118-9-199305010-00006

Gross, 1977, Pulmonary effects of radiation therapy, Ann Intern Med, 86, 81, 10.7326/0003-4819-86-1-81

Fryer, 1978, Radiation pneumonitis: Experience following a large single dose of radiation, Int J Radiat Oncol Biol Phys, 4, 931, 10.1016/0360-3016(78)90002-0

Chen, 2001, Circulating IL-6 as a predictor of radiation pneumonitis, Int J Radiat Oncol Biol Phys, 49, 641, 10.1016/S0360-3016(00)01445-0

Anscher, 1998, Plasma transforming growth factor β1 as a predictor of radiation pneumonitis, Int J Radiat Oncol Biol Phys, 41, 1029, 10.1016/S0360-3016(98)00154-0

Rubin, 1995, A perpetual cascade of cytokines post-irradiation leads to pulmonary fibrosis, Int J Radiat Oncol Biol Phys, 33, 99, 10.1016/0360-3016(95)00095-G

Johnston, 1998, Alterations in the expression of chemokine mRNA levels in fibrosisresistant and -sensitive mice after thoracic irradiation, Exp Lung Res, 24, 321, 10.3109/01902149809041538

Kaseda, 2000, Possible role of L-selectin in T lymphocyte alveolitis in patients with active pulmonary sarcoidosis, Clin Exp Immunol, 121, 146, 10.1046/j.1365-2249.2000.01267.x

Butcher, 1996, Lymphocyte homing and homeostasis, Science, 272, 60, 10.1126/science.272.5258.60

McDonald, 1995, Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems, Int J Radiat Oncol Biol Phys, 31, 1187, 10.1016/0360-3016(94)00429-O

Antonia, 1995, Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage III A/B non-small cell carcinoma of the lung, Semin Oncol, 22, 34

Reekzeh, 1996, Severe lymphocytopenia and interstitial pneumonia in patients treated with paelitaxel and simultaneous radiotherapy for non-small cell lung cancer, J Clin Oncol, 14, 1071, 10.1200/JCO.1996.14.4.1071

Antonadou, 1999, Randomized phase III trial of radiation ± amifostine in patients with advanced stage lung cancer, Int J Radiat Oncol Biol Phys, 45, 154, 10.1016/S0360-3016(99)90036-6

Schuyler, 2000, Mediators of hypersensitivity pneumonitis, J Lab Clin Med, 136, 29, 10.1067/mlc.2000.107694

Ding, 2000, Regulation of chemokine-induced transendothelial migration of T lymphocytes by endothelial activation: Differential effects on naïve and memory T cells, J Leukoc Biol, 67, 825, 10.1002/jlb.67.6.825

Maasilta, 1993, Bronchoalveolar lavage fluid findings following radiotherapy for non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 26, 117, 10.1016/0360-3016(93)90181-T

De Boer, 2000, Monocyte chemoattractant protein I, interleukin 8, and chronic airways inflammation in COPD, J Pathol, 190, 619, 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6

Kovasc, 1991, Fibrogenic cytokines: The role of immune mediators in the development of scar tissue, Immunol Today, 12, 17, 10.1016/0167-5699(91)90107-5

Elias, 1985, Differential interleukin-1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: Relationship to cell maturity, J Immunol, 135, 3198, 10.4049/jimmunol.135.5.3198

Kotloff, 1990, Human alveolar macrophage and blood monocyte interleukin-6 production, Am J Respir Cell Mol Biol, 3, 497, 10.1165/ajrcmb/3.5.497

Simeonova, 1997, Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: Role of reactive oxygen species, J Immunol, 159, 3921, 10.4049/jimmunol.159.8.3921

O'Brien-Lander, 1993, Release of interleukin-1 by human alveolar macrophages after in vitro irradiation, Radiat Res, 136, 37, 10.2307/3578637

Elias, 1990, IL-1 and tumor necrosis factor synergistically stimulate fibroblasts IL-6 production and stabilize IL-6 messenger RNA, J Immunol, 145, 161, 10.4049/jimmunol.145.1.161

Helle, 1988, Interleukin 6 is involved in interleukin 1-induced activities, Eur J Immunol, 18, 957, 10.1002/eji.1830180619

Roach, 1995, Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors, J Clin Oncol, 13, 2606, 10.1200/JCO.1995.13.10.2606

Kimsey, 1994, Is radiation treatment volume a predictor for acute or late effect on pulmonary function, Cancer, 73, 2549, 10.1002/1097-0142(19940515)73:10<2549::AID-CNCR2820731016>3.0.CO;2-N

Byhardt, 1993, The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC): Analysis of a Radiation Therapy Oncology Group (RTOG) Protocol, Int J Radiat Oncol Biol Phys, 27, 537, 10.1016/0360-3016(93)90377-8

Kwa, 1998, Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients, Int J Radiat Oncol Biol Phys, 42, 1, 10.1016/S0360-3016(98)00196-5